GMED Net Income Growth
50.14%TTM
Period ending:
GMED TTM Net Income YoY %%
879.66%-182.92%
2012-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
GMED net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 55 observations from Dec 31, 2012 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 50.1372% | |
| 216.1945% | |
| 422.3141% | |
| 363.0807% | |
| 776.8261% | |
| 178.5102% | |
| -16.1866% | |
| -42.0452% | |
| -80.0942% | |
| -66.8877% | |
| -35.3878% | |
| 1.7351% | |
| 31.838% | |
| 41.7546% | |
| 27.4675% | |
| -17.0181% | |
| -15.7873% | |
| 16.6695% | |
| 45.8581% | |
| 97.1831% | |
| 106.9153% | |
| -17.765% | |
| -34.0985% | |
| -35.2202% | |
| -37.9422% | |
| -1.4633% | |
| -0.8078% | |
| 1.6176% | |
| 6.5801% | |
| 27.0563% | |
| 45.7624% | |
| 34.333% | |
| 24.6288% | |
| 12.4965% | |
| 2.8819% | |
| -8.8181% | |
| -8.4751% | |
| -9.5578% | |
| -7.486% | |
| 14.4163% | |
| 18.6085% | |
| 20.993% | |
| 21.9484% | |
| 19.7933% | |
| 19.6435% | |
| 37.4091% | |
| 34.7942% | |
| 25.4964% | |
| 28.6661% | |
| -8.2552% | |
| -7.0688% | |
| 2.6413% | |
| -3.6398% | |
| 19.1103% | |
| 21.4645% |
Compare net income growth
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) net income growth
- HSBC Holdings, plc. Common Stock (HSBC) net income growth
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) net income growth
- Novartis AG Common Stock (NVS) net income growth
- Royal Bank Of Canada Common Stock (RY) net income growth
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) net income growth
- SAP SE ADS (SAP) net income growth
- AstraZeneca PLC Ordinary Shares (AZN) net income growth
Compare all covered stocks by net income growth →
All GMED financial metrics · GMED stock overview · How to interpret financial metrics
